Clonal associations of lymphocyte subsets and functional states revealed by single cell antigen receptor profiling of T and B cells in rheumatoid arthritis synovium.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
21 Mar 2023
21 Mar 2023
Historique:
pubmed:
31
3
2023
medline:
31
3
2023
entrez:
30
3
2023
Statut:
epublish
Résumé
Rheumatoid arthritis (RA) is an autoimmune disease initiated by antigen-specific T cells and B cells, which promote synovial inflammation through a complex set of interactions with innate immune and stromal cells. To better understand the phenotypes and clonal relationships of synovial T and B cells, we performed single-cell RNA and repertoire sequencing on paired synovial tissue and peripheral blood samples from 12 donors with seropositive RA ranging from early to chronic disease. Paired transcriptomic-repertoire analyses highlighted 3 clonally distinct CD4 T cells populations that were enriched in RA synovium: T peripheral helper (Tph) and T follicular helper (Tfh) cells, CCL5+ T cells, and T regulatory cells (Tregs). Among these cells, Tph cells showed a unique transcriptomic signature of recent T cell receptor (TCR) activation, and clonally expanded Tph cells expressed an elevated transcriptomic effector signature compared to non-expanded Tph cells. CD8 T cells showed higher oligoclonality than CD4 T cells, and the largest CD8 T cell clones in synovium were highly enriched in
Identifiants
pubmed: 36993527
doi: 10.1101/2023.03.18.533282
pmc: PMC10055242
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAMS NIH HHS
ID : K08 AR072791
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR077037
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Déclaration de conflit d'intérêts
Competing Interests K.W. received a sponsored-research agreement from Gilead Sciences, and served as a consultant for Gilead Sciences and Horizon Therapeutics.